Home Novo Nordisk (NVO.US) to Limit Wegovy Shipments in China to Prevent Supply Disruptions

Novo Nordisk (NVO.US) to Limit Wegovy Shipments in China to Prevent Supply Disruptions

Jun 27, 2024 18:52 CST Updated 18:52
Novo Nordisk

Insulin Developer and Manufacturer

Gelonghui June 27 | Novo Nordisk (NVO.US): Will limit the shipment of weight-loss drug Wegovy in China to avoid supply disruptions.